University of Exeter Medical School

Dr Richard Oram

Dr Richard Oram

Associate Professor, Diabetes UK Harry Keen Fellow

 R.Oram@exeter.ac.uk

 +44 (0) 1392 406819

 NIHR Exeter Clinical Research Facility 

Overview

Professor Richard Oram is a Diabetes UK Harry Keen Fellow specializing in Type 1 diabetes at the Institute of Biomedical and Clinical Science and NIHR Exeter Clinical Research Facility. Richard finished his Diabetes UK funded PhD on endogenous insulin production in type 1 diabetes in 2014, he showed that most people with type 1 diabetes still make small amounts of their own insulin. Funded by JDRF, he continues to study the biology of beta cell loss in type 1 diabetes and the impact of persistent beta cell function on complications, including hypoglycemia. His Harry Keen fellowship and the Helmsley Charitable Trust fund Richard and Tim Tree (KCL) to study the causes of a rare subtype of extremely early onset type 1 diabetes - diagnosed under the age of 1 year. This overlaps with work with Sarah Richardson, Noel Morgan, Andrew Hattersley and Tim McDonald to better define endotypes of type 1 diabetes.  

Working with Mike Weedon, he has developed a cheap, simple method to assess genetic risk in type 1 diabetes – a T1D genetic risk score (T1D GRS). He has shown this can be used as a diagnostic test to differentiate type 1 and type 2 diabetes, and with Kash Patel has shown it can be used to identify monogenic diabetes. Collaborating with Bill Hagopian (PNRI, Seattle), he recently improved the T1D GRS to include more HLA alleles and their interactions. With Ranjan Yajnik (Pune, India), he has shown the utility of this T1D genetic risk score in Indians. With Mike Weedon, Bill Hagopian and the NIH funded SEARCH study, Richard is working of uses of the T1D GRS in an ethnically diverse US population. 

Richard is testing the utility of the T1D GRS for prediciton of Type 1 diabetes. Funded by JDRF, with Bill Hagopian, Lauric Ferrat and Kendra Vehik, he is investigating combining genetic information with longitudinal biomarkers to better predict type 1 diabetes and other autoimmune diseases from birth in the NIH funded TEDDY study. He is coinvestigator with with Maria Redondo (Baylor College of Medicine) to intergrate genetics into better prediciton of type 1 diabetes in the NIH funded Trialnet Pathway to Prevention study. Richard is working with Bill Hagopian to test a newborn genetic screen with autoantibody monitoring follow up to prevent childhood diabetic ketoacidosis in the CASCADE study.

Richard spent a period of his training at the University of Alberta with the world leading clinical islet transplant and renal transplant programs. During this time he performed analysis of complications related to immunosuppression post-islet transplantation, and with Peter Senior and Shareen Forbes developed a new method to assess graft function - The Beta2 Score.

Qualifications

PhD, BMBCh, BA(hons), MRCP

Research group links

Back to top

Research

Research interests

Biology of type 1 diabetes

Beta cell function in type 1 diabetes

Polygenic risk scores in autoimmune disease

Research projects

EXE T1D - study of extremely early onset type 1 diabetes (https://www.diabetesgenes.org/current-research/exe-t1d/)

TIGI - study of persistent beta cell fuction in type 1 diabetes

T1D GRS - use of type 1 diabetes genetic risk score for prediciton and diagnosis of type 1 diabetes

Celiac GRS - combined prediciton and diagnosis of celiac disease using genetics

Research grants

  • 2019 Juvenile Diabetes Research Foundation
    Improved, cost effective prediction of type 1 diabetes in early life using combined prediction models
  • 2017 Diabetes UK
    This is a study of the mechanisms that lead to children presenting with autoimmune type 1 diabetes in the first year of life, before the immune system has fully developed.
  • 2017 The Helmsley Charitable Trust
    Immune Mechanisms of Extremely Early onset type 1 diabetes
  • 2014 Juvenile Diabetes Research Foundation
    This is a study the investigates the mechanisms of persistent C-peptide in Type 1 Diabetes

Back to top

Publications

Journal articles

Bailey S, Green H, Merriel S, Oram R, Thirlwell C, Ruth K, Tyrrell J, Weedon M (In Press). Applying a genetic risk score for prostate cancer to men with lower urinary tract symptoms in primary care to predict prostate cancer diagnosis: a cohort study in the UK Biobank. British Journal of Cancer
Hope S, Wienand-Barnett S, Shepherd M, King S, Fox C, Khunti K, Oram R, Knight B, Hattersley A, Jones A, et al (In Press). Assessment of Practical Classification Guidelines for Diabetes in insulin-treated patients. British Journal of General Practice
Oram RA, Weedon M, Wood A, Beaumont R, Tyrrell J (In Press). Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis. Diabetes Care
Lynam A, McDonald T, Hill A, Dennis J, Oram R, Pearson E, Weedon M, Hattersley A, Owen K, Shields B, et al (In Press). Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18 to 50. BMJ Open
Green H, Weedon M (In Press). Hyperglycemia is a causal risk factor for upper limb pathologies. International Journal of Epidemiology Abstract.
Leete P, Oram R, McDonald T, Ziller C, Hattersley A, Richardson S, Morgan N (In Press). Studies of insulin and proinsulin in pancreas and serum support the existence of aetiopathological endotypes of type 1 diabetes associated with age at diagnosis. Diabetologia
Johnson M, Patel K, De Franco E, McDonald T, Hudson M, Dobbs R, Ellard S, Flanagan S, Hattersley A, Oram R, et al (In Press). Type 1 Diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta-cells. Diabetologia
Loginovic P, Wang F, Li J, Ferrat L, Mirshahi UL, Rao HS, Petzold A, Tyrrell J, Green HD, Weedon MN, et al (2024). Applying a genetic risk score model to enhance prediction of future multiple sclerosis diagnosis at first presentation with optic neuritis. Nature Communications, 15(1). Abstract.
Jones AG, Shields BM, Oram RA, Dabelea DM, Hagopian WA, Lustigova E, Shah AS, Knupp J, Mottl AK, D’Agostino RB, et al (2024). Clinical Prediction Models Combining Routine Clinical Measures Have High Accuracy in Identifying Youth-Onset Type 2 Diabetes Defined by Maintained Endogenous Insulin Secretion: the SEARCH for Diabetes in Youth Study. Diabetes Care Abstract.
Redondo MJ, Harrall KK, Glueck DH, Tosur M, Uysal S, Muir A, Atkinson EG, Shapiro MR, Yu L, Winter WE, et al (2024). Diabetes Study of Children of Diverse Ethnicity and Race: Study design. Diabetes Metab Res Rev, 40(3). Abstract.  Author URL.
FUHRI SNETHAGE C, MCDONALD TJ, RAMPANELLI E, DE GROEN P, SCHIMMEL AWM, VAN RAALTE D, BROUWER CB, ORAM RA, ROEP BO, NIEUWDORP M, et al (2023). 27-OR: Residual Beta-Cell Function Associates with Lower Glycaemic Variability and More Time in Range in Individuals with Type 1 Diabetes. Diabetes, 72(Supplement_1).
Zhou Y, Chia MA, Wagner SK, Ayhan MS, Williamson DJ, Struyven RR, Liu T, Xu M, Lozano MG, Woodward-Court P, et al (2023). A foundation model for generalizable disease detection from retinal images. Nature, 622(7981), 156-163. Abstract.
Thomas NJ, Hill AV, Dayan CM, Oram RA, McDonald TJ, Shields BM, Jones AG, Simon G, Ramos A, Norris A, et al (2023). Age of Diagnosis Does Not Alter the Presentation or Progression of Robustly Defined Adult-Onset Type 1 Diabetes. Diabetes Care, 46(6), 1156-1163. Abstract.
Warwick AN, Curran K, Hamill B, Stuart K, Khawaja AP, Foster PJ, Lotery AJ, Quinn M, Madhusudhan S, Balaskas K, et al (2023). Correction: UK Biobank retinal imaging grading: methodology, baseline characteristics and findings for common ocular diseases (Eye, (2023), 37, 10, (2109-2116), 10.1038/s41433-022-02298-7). Eye (Basingstoke), 37(10). Abstract.
Felton JL, Griffin KJ, Oram RA, Speake C, Long SA, Onengut-Gumuscu S, Rich SS, Monaco GSF, Evans-Molina C, DiMeglio LA, et al (2023). Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review. Commun Med (Lond), 3(1). Abstract.  Author URL.
Squires S, Weedon MN, Oram RA (2023). Exploring the application of deep learning methods for polygenic risk score estimation. medRxiv Abstract.  Author URL.
McGrail C, Chiou J, Elgamal R, Luckett AM, Oram RA, Benaglio P, Gaulton KJ (2023). Genetic discovery and risk prediction for type 1 diabetes in individuals without high-risk HLA-DR3/DR4 haplotypes. medRxiv Abstract.  Author URL.
Allen LA, Taylor PN, Gillespie KM, Oram RA, Dayan CM (2023). Maternal type 1 diabetes and relative protection against offspring transmission. Lancet Diabetes Endocrinol, 11(10), 755-767. Abstract.  Author URL.
Fuhri Snethlage CM, McDonald TJ, Oram RD, de Groen P, Rampanelli E, Schimmel AWM, Holleman F, Siegelaar S, Hoekstra J, Brouwer CB, et al (2023). Residual β-Cell Function is Associated with Longer Time in Range in Individuals with Type 1 Diabetes. Diabetes Care Abstract.
Green HD, Merriel SWD, Oram RA, Ruth KS, Tyrrell J, Jones SE, Thirlwell C, Weedon MN, Bailey SER (2023). Response to: Genetic risk scores may compound rather than solve the issue of prostate cancer overdiagnosis (BJC-LT3342090). Br J Cancer, 128(4), 487-488.  Author URL.
Tobias DK, Merino J, Ahmad A, Aiken C, Benham JL, Bodhini D, Clark AL, Colclough K, Corcoy R, Cromer SJ, et al (2023). Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. Nature Medicine, 29(10), 2438-2457.
Evans-Molina C, Oram RA (2023). Teplizumab approval for type 1 diabetes in the USA. Lancet Diabetes Endocrinol, 11(2), 76-77.  Author URL.
Osafehinti D, Mulukutla SN, Hampe CS, Gaba R, Ram N, Weedon MN, Oram RA, Balasubramanyam A (2023). Type 1 Diabetes Genetic Risk Score Differentiates Subgroups of Ketosis-Prone Diabetes. Diabetes Care, 46(10), 1778-1782. Abstract.  Author URL.
You L, Ferrat LA, Oram RA, Parikh HM, Steck AK, Krischer J, Redondo MJ, Type 1 Diabetes TrialNet Study Group (2023). Type 1 Diabetes Risk Phenotypes Using Cluster Analysis. medRxiv Abstract.  Author URL.
Warwick AN, Curran K, Hamill B, Stuart K, Khawaja AP, Foster PJ, Lotery AJ, Quinn M, Madhusudhan S, Balaskas K, et al (2023). UK Biobank retinal imaging grading: methodology, baseline characteristics and findings for common ocular diseases. Eye (Basingstoke), 37(10), 2109-2116. Abstract.
Luckett AM, Weedon MN, Hawkes G, Leslie RD, Oram RA, Grant SFA (2023). Utility of genetic risk scores in type 1 diabetes. Diabetologia, 66(9), 1589-1600. Abstract.  Author URL.
SHARP SA, LOCKE JM, XU Y, FRASER DP, FERRAT LA, WEEDON MN, INOUYE M, ORAM RA, HAGOPIAN W (2022). 188-LB: Deep Learning–Based Population Screening of Type 1 Diabetes and Celiac Disease Genetic Risk from Blood Spots at Birth. Diabetes, 71(Supplement_1).
Ferrat LA, Vehik K, Sharp SA, Lernmark Å, Rewers MJ, She J-X, Ziegler A-G, Toppari J, Akolkar B, Krischer JP, et al (2022). Author Correction: a combined risk score enhances prediction of type 1 diabetes among susceptible children. Nat Med, 28(3).  Author URL.
Taylor GS, Shaw AC, Smith K, Wason J, McDonald TJ, Oram RA, Stevenson E, Shaw JAM, West DJ (2022). Capturing the real-world benefit of residual β-cell function during clinically important time-periods in established Type 1 diabetes. Diabet Med, 39(5). Abstract.  Author URL.
Carr ALJ, Inshaw JRJ, Flaxman CS, Leete P, Wyatt RC, Russell LA, Palmer M, Prasolov D, Worthington T, Hull B, et al (2022). Circulating C-Peptide Levels in Living Children and Young People and Pancreatic β-Cell Loss in Pancreas Donors Across Type 1 Diabetes Disease Duration. Diabetes, 71(7), 1591-1596. Abstract.
Jiang G, Luk AO, Tam CHT, Ozaki R, Lim CKP, Chow EYK, Lau ES, Kong APS, Fan B, Hong Kong Diabetes Register TRS Study Group, et al (2022). Clinical Predictors and Long-term Impact of Acute Kidney Injury on Progression of Diabetic Kidney Disease in Chinese Patients with Type 2 Diabetes. Diabetes, 71(3), 520-529. Abstract.  Author URL.
Wyatt RC, Hagopian WA, Roep BO, Patel KA, Resnick B, Dobbs R, Hudson M, EXE-T1D Consortium, De Franco E, Ellard S, et al (2022). Congenital beta cell defects are not associated with markers of islet autoimmunity, even in the context of high genetic risk for type 1 diabetes. Diabetologia, 65(7), 1179-1184. Abstract.  Author URL.
Lam A, Oram RA, Forbes S, Olateju T, Malcolm AJ, Imes S, Shapiro AMJ, Senior PA (2022). Estimation of Early Graft Function Using the BETA-2 Score Following Clinical Islet Transplantation. TRANSPLANT INTERNATIONAL, 35  Author URL.
Libman I, Haynes A, Lyons S, Pradeep P, Rwagasor E, Tung JY-L, Jefferies CA, Oram RA, Dabelea D, Craig ME, et al (2022). ISPAD Clinical Practice Consensus Guidelines 2022: Definition, epidemiology, and classification of diabetes in children and adolescents. Pediatr Diabetes, 23(8), 1160-1174.  Author URL.
Gilchrist M, Casanova F, Tyrrell JS, Cannon S, Wood AR, Fife N, Young K, Oram RA, Weedon MN (2022). Prevalence of Fabry disease-causing variants in the UK Biobank. Journal of Medical Genetics, 60(4), 391-396. Abstract.
Cannon S, Clissold R, Sukcharoen K, Tuke M, Hawkes G, Beaumont RN, Wood AR, Gilchrist M, Hattersley AT, Oram RA, et al (2022). Recurrent 17q12 microduplications contribute to renal disease but not diabetes. Journal of Medical Genetics, 60(5), 491-497. Abstract.
Meek CL, Oram RA, McDonald TJ, Feig DS, Hattersley AT, Murphy HR (2022). Response to Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834. Diabetes Care, 45(2), e43-e44.  Author URL.
Harding JL, Wander PL, Zhang X, Li X, Karuranga S, Chen H, Sun H, Xie Y, Oram RA, Magliano DJ, et al (2022). The Incidence of Adult-Onset Type 1 Diabetes: a Systematic Review from 32 Countries and Regions. Diabetes Care, 45(4), 994-1006. Abstract.  Author URL.
Redondo MJ, Gignoux CR, Dabelea D, Hagopian WA, Onengut-Gumuscu S, Oram RA, Rich SS (2022). Type 1 diabetes in diverse ancestries and the use of genetic risk scores. Lancet Diabetes Endocrinol, 10(8), 597-608. Abstract.  Author URL.
Oram RA, Sharp SA, Pihoker C, Ferrat L, Imperatore G, Williams A, Redondo MJ, Wagenknecht L, Dolan LM, Lawrence JM, et al (2022). Utility of Diabetes Type-Specific Genetic Risk Scores for the Classification of Diabetes Type Among Multiethnic Youth. Diabetes Care, 45(5), 1124-1131. Abstract.  Author URL.
Sims EK, Carr ALJ, Oram RA, DiMeglio LA, Evans-Molina C (2021). 100 years of insulin: celebrating the past, present and future of diabetes therapy. Nat Med, 27(7), 1154-1164. Abstract.  Author URL.
CARR A, ORAM RA, NARENDRAN P, ANDREWS RC (2021). 153-OR: Measurement of C-Peptide at Diagnosis Informs Glycemic Control but Not Hypoglycemic Risk in Type 1 Diabetes. Diabetes, 70(Supplement_1).
FERRAT LA, STECK A, PARIKH HM, YOU L, ONENGUT-GUMUSCU S, GOTTLIEB P, RICH SS, KRISCHER J, ORAM RA, REDONDO MJ, et al (2021). 243-OR: Integrating Genetic Risk Score and Islet Autoantibody Characteristics in the Predictive Model for Type 1 Diabetes in the TrialNet Study. Diabetes, 70(Supplement_1).
MEEK CL, ORAM RA, MCDONALD TJ, FEIG D, HATTERSLEY AT, MURPHY HR (2021). 94-OR: Reappearance of C-Peptide during the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism?. Diabetes, 70(Supplement_1).
Thomas NJ, Dennis JM, Sharp SA, Kaur A, Misra S, Walkey HC, Johnston DG, Oliver NS, Hagopian WA, Weedon MN, et al (2021). Correction to: DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life. Diabetologia, 65(1), 258-258.
Thomas NJ, Dennis JM, Sharp SA, Kaur A, Misra S, Walkey HC, Johnston DG, Oliver NS, Hagopian WA, Weedon MN, et al (2021). DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life. Diabetologia, 64(10), 2258-2265. Abstract.  Author URL.
Evans BD, Słowiński P, Hattersley AT, Jones SE, Sharp S, Kimmitt RA, Weedon MN, Oram RA, Tsaneva-Atanasova K, Thomas NJ, et al (2021). Estimating disease prevalence in large datasets using genetic risk scores. Nature Communications, 12(1). Abstract.
Hiller H, Beachy DE, Lebowitz JJ, Engler S, Mason JR, Miller DR, Kusmarteva I, Jacobsen LM, Posgai AL, Khoshbouei H, et al (2021). Monogenic Diabetes and Integrated Stress Response Genes Display Altered Gene Expression in Type 1 Diabetes. Diabetes, 70(8), 1885-1897. Abstract.  Author URL.
Dayan CM, Besser REJ, Oram RA, Hagopian W, Vatish M, Bendor-Samuel O, Snape MD, Todd JA (2021). Preventing type 1 diabetes in childhood. Science, 373(6554), 506-510. Abstract.  Author URL.
Meek CL, Oram RA, McDonald TJ, Feig DS, Hattersley AT, Murphy HR, CONCEPTT Collaborative Group (2021). Reappearance of C-Peptide During the Third Trimester of Pregnancy in Type 1 Diabetes: Pancreatic Regeneration or Fetal Hyperinsulinism?. Diabetes Care, 44(8), 1826-1834. Abstract.  Author URL.
TAYLOR GS, SMITH K, SCRAGG J, BASHIR A, FLATT A, STEVENSON EJ, MCDONALD TJ, ORAM RA, SHAW JA, ROSS MD, et al (2020). 680-P: Residual ß-Cell Function in Long-Term Type 1 Diabetes is Associated with a Fivefold Greater Mobilization of Endothelial Progenitor Cells after Exercise. Diabetes, 69(Supplement_1).
Ferrat LA, Vehik K, Sharp SA, Lernmark A, Rewers MJ, She J-X, Ziegler A-G, Toppari J, Akolkar B, Krischer JP, et al (2020). A combined risk score enhances prediction of type 1 diabetes among susceptible children. NATURE MEDICINE, 26(8), 1247-+.  Author URL.
Sharp SA, Jones SE, Kimmitt RA, Weedon MN, Halpin AM, Wood AR, Beaumont RN, King S, van Heel DA, Campbell PM, et al (2020). A single nucleotide polymorphism genetic risk score to aid diagnosis of coeliac disease: a pilot study in clinical care. Alimentary Pharmacology & Therapeutics, 52(7), 1165-1173. Abstract.
Evans BD, Słowiński P, Hattersley AT, Jones SE, Sharp S, Kimmitt RA, Weedon MN, Oram RA, Tsaneva-Atanasova K, Thomas NJ, et al (2020). Estimating population level disease prevalence using genetic risk scores. Abstract.
Carr ALJ, Perry DJ, Lynam AL, Chamala S, Flaxman CS, Sharp SA, Ferrat LA, Jones AG, Beery ML, Jacobsen LM, et al (2020). Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes. Diabetic Medicine, 37(12), 2160-2168. Abstract.
Sukcharoen K, Sharp SA, Thomas NJ, Kimmitt RA, Harrison J, Bingham C, Mozere M, Weedon MN, Tyrrell J, Barratt J, et al (2020). IgA Nephropathy Genetic Risk Score to Estimate the Prevalence of IgA Nephropathy in UK Biobank. Kidney International Reports, 5(10), 1643-1650. Abstract.
Battaglia M, Ahmed S, Anderson MS, Atkinson MA, Becker D, Bingley PJ, Bosi E, Brusko TM, DiMeglio LA, Evans-Molina C, et al (2020). Introducing the Endotype Concept to Address the Challenge of Disease Heterogeneity in Type 1 Diabetes. Diabetes Care, 43(1), 5-12. Abstract.  Author URL.
Lynam AL, Dennis JM, Owen KR, Oram RA, Jones AG, Shields BM, Ferrat LA (2020). Logistic regression has similar performance to optimised machine learning algorithms in a clinical setting: application to the discrimination between type 1 and type 2 diabetes in young adults. Diagnostic and Prognostic Research, 4(1). Abstract.
Locke JM, Latten MJ, Datta RY, Wood AR, Crockard MA, Lamont JV, Weedon MN, Oram RA (2020). Methods for quick, accurate and cost-effective determination of the type 1 diabetes genetic risk score (T1D-GRS). Clin Chem Lab Med, 58(4), e102-e104.  Author URL.
Taylor GS, Smith K, Capper TE, Scragg JH, Bashir A, Flatt A, Stevenson EJ, McDonald TJ, Oram RA, Shaw JA, et al (2020). Postexercise Glycemic Control in Type 1 Diabetes is Associated with Residual β-Cell Function. Diabetes Care, 43(10), 2362-2370. Abstract.
Redondo MJ, Hagopian WA, Oram R, Steck AK, Vehik K, Weedon M, Balasubramanyam A, Dabelea D (2020). The clinical consequences of heterogeneity within and between different diabetes types. Diabetologia, 63(10), 2040-2048. Abstract.
Harrison JW, Tallapragada DSP, Baptist A, Sharp SA, Bhaskar S, Jog KS, Patel KA, Weedon MN, Chandak GR, Yajnik CS, et al (2020). Type 1 diabetes genetic risk score is discriminative of diabetes in non-Europeans: evidence from a study in India. Scientific Reports, 10(1). Abstract.
TAYLOR GS, SMITH K, SCRAGG J, BASHIR A, ORAM RA, MCDONALD TJ, STEVENSON EJ, SHAW JA, WEST DJ (2019). 294-OR: Type 1 Diabetes Patients with Residual Beta-Cell Function Display Improved Time in Euglycemia and Less Glycaemic Fluctuation after Exercise. Diabetes, 68(Supplement_1).
Ocaña GJ, Sims EK, Watkins RA, Ragg S, Mather KJ, Oram RA, Mirmira RG, DiMeglio LA, Blum JS, Evans-Molina C, et al (2019). Analysis of serum Hsp90 as a potential biomarker of β cell autoimmunity in type 1 diabetes. PLoS One, 14(1). Abstract.  Author URL.
Oram RA, Sims EK, Evans-Molina C (2019). Beta cells in type 1 diabetes: mass and function; sleeping or dead?. Diabetologia, 62(4), 567-577. Abstract.  Author URL.
Oram RA, Redondo MJ (2019). New insights on the genetics of type 1 diabetes. Curr Opin Endocrinol Diabetes Obes, 26(4), 181-187. Abstract.  Author URL.
Marren SM, Hammersley S, McDonald TJ, Shields BM, Knight BA, Hill A, Bolt R, Tree TI, Roep BO, Hattersley AT, et al (2019). Persistent C-peptide is associated with reduced hypoglycaemia but not HbA1c in adults with longstanding Type 1 diabetes: evidence for lack of intensive treatment in UK clinical practice?. Diabet Med, 36(9), 1092-1099. Abstract.  Author URL.
Grubb A, McDonald T, Rutters F, Donnelly L, Hattersley A, Oram R, Palmer C, van der Heijden A, Carr F, Elders P, et al (2018). A Type 1 Diabetes Genetic Risk Score can Identify Patients with GAD65 Autoantibody–Positive Type 2 Diabetes Who Rapidly Progress to Insulin Therapy. Diabetes Care
Redondo MJ, Geyer S, Steck AK, Sharp S, Wentworth JM, Weedon MN, Antinozzi P, Sosenko J, Atkinson M, Pugliese A, et al (2018). A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk. Diabetes Care, 41(9), 1887-1894. Abstract.
Perry DJ, Wasserfall CH, Oram RA, Williams MD, Posgai A, Muir AB, Haller MJ, Schatz DA, Wallet MA, Mathews CE, et al (2018). Application of a Genetic Risk Score to Racially Diverse Type 1 Diabetes Populations Demonstrates the Need for Diversity in Risk-Modeling. Sci Rep, 8(1). Abstract.  Author URL.
Shields B, McDonald T, Oram R, Hill A, Hudson M, Leete P, Pearson E, Richardson S, Morgan N, Hattersley A, et al (2018). C-peptide decline in type 1 diabetes has two phases: an initial exponential fall and a subsequent stable phase. Diabetes Care
Ling Y, Gill A, Oram R, Shapiro AMJ, Senior P (2018). Clinical Islet Transplantation for Adults with Type 1 Diabetes in Canada: Referral Patterns and Eligibility Assessment. Can J Diabetes, 42(4), 419-425. Abstract.  Author URL.
Sharp SA, Weedon MN, Hagopian WA, Oram RA (2018). Clinical and research uses of genetic risk scores in type 1 diabetes. Curr Opin Genet Dev, 50, 96-102. Abstract.  Author URL.
Thomas NJ, Jones SE, Weedon MN, Shields BM, Oram RA, Hattersley AT (2018). Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol, 6(2), 122-129. Abstract.  Author URL.
Thomas NJ, Jones SE, Weedon MN, Shields BM, Hattersley AT, Oram RA (2018). Genetic risk scores in adult-onset type 1 diabetes - Authors' reply. Lancet Diabetes Endocrinol, 6(3).  Author URL.
Bonifacio E, Beyerlein A, Hippich M, Winkler C, Vehik K, Weedon MN, Laimighofer M, Hattersley AT, Krumsiek J, Frohnert BI, et al (2018). Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: a prospective study in children. PLoS Med, 15(4). Abstract.  Author URL.
Roshandel D, Gubitosi-Klug R, Bull SB, Canty AJ, Pezzolesi MG, King GL, Keenan HA, Snell-Bergeon JK, Maahs DM, Klein R, et al (2018). Meta-genome-wide association studies identify a locus on chromosome 1 and multiple variants in the MHC region for serum C-peptide in type 1 diabetes. Diabetologia, 61(5), 1098-1111. Abstract.  Author URL.
Thomas N, Grubb A, McDonald T, Hill A, Weedon M, Oram R, Hattersley A, Jones A (2018). Type 1 diabetes leading to severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes in clinical practice. DIABETOLOGIA, 61, S152-S152.  Author URL.
DiMeglio LA, Evans-Molina C, Oram RA (2018). Type 1 diabetes. Lancet, 391(10138), 2449-2462. Abstract.  Author URL.
Redondo MJ, Oram RA, Steck AK (2017). Genetic Risk Scores for Type 1 Diabetes Prediction and Diagnosis. Curr Diab Rep, 17(12). Abstract.  Author URL.
Oram RA, Patel K, Hill A, Shields B, McDonald TJ, Jones A, Hattersley AT, Weedon MN (2016). A Type 1 Diabetes Genetic Risk Score can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults. Diabetes Care, 39(3), 337-344. Abstract.  Author URL.
Heap GA, So K, Weedon M, Edney N, Bewshea C, Singh A, Annese V, Beckly J, Buurman D, Chaudhary R, et al (2016). Clinical Features and HLA Association of 5-Aminosalicylate (5-ASA)-induced Nephrotoxicity in Inflammatory Bowel Disease. J Crohns Colitis, 10(2), 149-158. Abstract.  Author URL.
Seelig E, Timper K, Falconnier C, Stoeckli R, Bilz S, Oram R, McDonald TJ, Donath MY (2016). Interleukin-1 antagonism in type 1 diabetes of long duration. Diabetes Metab, 42(6), 453-456.  Author URL.
Amed S, Oram R (2016). Maturity-Onset Diabetes of the Young (MODY): Making the Right Diagnosis to Optimize Treatment. Can J Diabetes, 40(5), 449-454. Abstract.  Author URL.
Shepherd M, Shields B, Hammersley S, Hudson M, McDonald TJ, Colclough K, Oram RA, Knight B, Hyde C, Cox J, et al (2016). Systematic Population Screening, Using Biomarkers and Genetic Testing, Identifies 2.5% of the U.K. Pediatric Diabetes Population with Monogenic Diabetes. Diabetes Care, 39(11), 1879-1888. Abstract.  Author URL.
Patel KA, Oram RA, Flanagan SE, De Franco E, Colclough K, Shepherd M, Ellard S, Weedon MN, Hattersley AT (2016). Type 1 Diabetes Genetic Risk Score: a Novel Tool to Discriminate Monogenic and Type 1 Diabetes. Diabetes, 65(7), 2094-2099. Abstract.
Oram RA, Hill A, Mcdonald TJ, Patel KA, Jones AG, Hattersley AT, Weedon MN (2015). 3. A Novel, Inexpensive Test can Discriminate between Type 1 and Type 2 Diabetes (1745-P). Nederlands Tijdschrift voor Diabetologie, 13(3), 57-57.
Brooks AM, Oram R, Home P, Steen N, Shaw JAM (2015). Demonstration of an intrinsic relationship between endogenous C-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantation. Diabetes Care, 38(1), 105-112. Abstract.  Author URL.
McDonald TJ, Oram RA, Vaidya B (2015). Investigating hyperkalaemia in adults. BMJ, 351  Author URL.
Oram RA, McDonald TJ, Shields BM, Hudson MM, Shepherd MH, Hammersley S, Pearson ER, Hattersley AT, UNITED Team (2015). Most people with long-duration type 1 diabetes in a large population-based study are insulin microsecretors. Diabetes Care, 38(2), 323-328. Abstract.  Author URL.
McDonald TJ, Oram RA, Vaidya B (2015). RATIONAL TESTING Investigating hyperkalaemia in adults. BMJ-BRITISH MEDICAL JOURNAL, 351  Author URL.
Oram RA, Jones AG, Besser RE, Knight BA, Shields BM, Brown RJ, Hattersley AT, McDonald TJ (2014). Erratum to: the majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia, 57(1).  Author URL.
Oram RA, Brooks AM, Forbes S, Eckoldt S, Smith RM, Choudhary P, Rosenthal MJ, Johnson P, Rutter MK, Burling KA, et al (2014). Home urine C-peptide creatinine ratio can be used to monitor islet transplant function. Diabetes Care, 37(6), 1737-1740. Abstract.  Author URL.
Hamilton AJ, Bingham C, McDonald TJ, Cook PR, Caswell RC, Weedon MN, Oram RA, Shields BM, Shepherd M, Inward CD, et al (2014). The HNF4A R76W mutation causes atypical dominant Fanconi syndrome in addition to a β cell phenotype. J Med Genet, 51(3), 165-169. Abstract.  Author URL.
Oram RA, Jones AG, Besser REJ, Knight BA, Shields BM, Brown RJ, Hattersley AT, McDonald TJ (2014). The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia, 57(1), 187-191. Abstract.
Oram RA, McDonald TJ, Vaidya B (2014). [In Process Citation]. Praxis (Bern 1994), 103(6), 341-345.  Author URL.
Weedon MN, Ellard S, Prindle MJ, Caswell R, Allen HL, Oram R, Godbole K, Yajnik CS, Sbraccia P, Novelli G, et al (2013). An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy. Nature Genetics, 45(8), 947-950. Abstract.
Weedon MN, Ellard S, Prindle MJ, Caswell R, Lango Allen H, Oram R, Godbole K, Yajnik CS, Sbraccia P, Novelli G, et al (2013). An in-frame deletion at the polymerase active site of POLD1 causes a multisystem disorder with lipodystrophy. Nat Genet, 45(8), 947-950. Abstract.  Author URL.
Oram RA, Jones AG, Besser REJ, Knight BA, Shields BM, Brown RJ, Hattersley AT, McDonald TJ (2013). Erratum to: the majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells. Diabetologia, 57(1), 262-262.
Edghill EL, Stals K, Oram RA, Shepherd MH, Hattersley AT, Ellard S (2013). HNF1B deletions in patients with young-onset diabetes but no known renal disease. Diabet Med, 30(1), 114-117. Abstract.  Author URL.
Oram RA, McDonald TJ, Vaidya B (2013). Investigating hypokalaemia. BMJ, 347  Author URL.
Eininger AK, Oram RA, Friend PJ, Asderakis A, Winearls CG, Hattersley AT, Owen KR (2013). Simultaneous pancreas and kidney transplantation (SPK) should be indicated for patients with maturity-onset diabetes of the young (MODY) and end-stage nephropathy. DIABETIC MEDICINE, 30, 92-93.  Author URL.
Oram RA, Rawlingson A, Shields BM, Bingham C, Besser REJ, McDonald TJ, Knight BA, Hattersley AT (2013). Urine C-peptide creatinine ratio can be used to assess insulin resistance and insulin production in people without diabetes: an observational study. BMJ Open, 3(12). Abstract.  Author URL.
Oram RA, Brooks AMS, Smith R, Rutter MK, Johnson PR, Choudhary P, Rosenthal M, Forbes S, McDonald TJ, Hattersley AT, et al (2013). Urine c-peptide creatinine ratio can be used for home monitoring of islet transplant function. DIABETIC MEDICINE, 30, 87-87.  Author URL.
Jones AG, Besser REJ, McDonald TJ, Shields BM, Hope SV, Bowman P, Oram RA, Knight BA, Hattersley AT (2011). Urine C-peptide creatinine ratio is an alternative to stimulated serum C-peptide measurement in late-onset, insulin-treated diabetes. Diabet Med, 28(9), 1034-1038. Abstract.  Author URL.
Oram RA, Edghill EL, Blackman J, Taylor MJO, Kay T, Flanagan SE, Ismail-Pratt I, Creighton SM, Ellard S, Hattersley AT, et al (2010). Mutations in the hepatocyte nuclear factor-1β (HNF1B) gene are common with combined uterine and renal malformations but are not found with isolated uterine malformations. Am J Obstet Gynecol, 203(4), 364.e1-364.e5. Abstract.  Author URL.
Oram RA, Edghill EL, Adalat S, Bockenhauer D, Ellard S, Woolf AS, Bingham C (2009). HNF1B MUTATIONS: REVIEW OF 109 AFFECTED PROBANDS. PEDIATRIC NEPHROLOGY, 24(9), 1804-1804.  Author URL.
Oram RA, Edghill EL, Woolf AS, Hennekam RC, Ellard S, Hattersley AT, Bingham C (2009). RET gene mutations are not a common cause of congenital solitary functioning kidney in adults. NDT Plus, 2(2), 183-184.
Edghill EL, Oram RA, Owens M, Stals KL, Harries LW, Hattersley AT, Ellard S, Bingham C (2008). Hepatocyte nuclear factor-1beta gene deletions--a common cause of renal disease. Nephrol Dial Transplant, 23(2), 627-635. Abstract.  Author URL.
Mytton OT, Simpson A, Thompson AAR, Oram RA, Darowski A, Yu LM, Collier DJ, Pollard AJ (2008). Manual assessment of the initial fall in blood pressure after orthostatic challenge at high altitude. Wilderness and Environmental Medicine, 19(4), 225-232. Abstract.
Forrest MS, Edwards SM, Houlston R, Kote-Jarai Z, Key T, Allen N, Knowles MA, Turner F, Ardern-Jones A, Murkin A, et al (2005). Association between hormonal genetic polymorphisms and early-onset prostate cancer. Prostate Cancer Prostatic Dis, 8(1), 95-102. Abstract.  Author URL.
Edwards SM, Kote-Jarai Z, Meitz J, Hamoudi R, Hope Q, Osin P, Jackson R, Southgate C, Singh R, Falconer A, et al (2003). Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene. American Journal of Human Genetics, 72(1), 1-12. Abstract.

Conferences

Luckett AM, Fraser DP, Weedon MN, Johnson MB, Rich SS, Oram RA (2023). Genetic risk score for type 1 diabetes in patients with early-onset type 1 diabetes: a potential application in newborn screening.  Author URL.
Allen LA, Mortimer GL, Fareed R, Williams CL, Bain S, Dayan CM, Fraser D, Hagopian W, Oram RA, Gillespie K, et al (2023). The reduction in genetic contribution to the incidence of childhood type 1 diabetes has stabilised over time.  Author URL.
JONES A, SHIELDS B, ORAM RA, DABELEA D, HAGOPIAN W, LUSTIGOVA E, SHAH AS, MOTTL AK, DAGOSTINO R, WILLIAMS AH, et al (2022). 985-P: Prediction Models Combining Clinical Measures Identify Participants with Youth-Onset Diabetes Who Maintain Insulin Secretion.
Dunne JL, Ferrat L, McQueen RB, Neusner R, Oram RA, Rewers M, Trusheim MR (2022). Childhood screening and interception strategies: an economic cohort simulation model.  Author URL.
Carr ALJ, Pickles J, Shields BM, Purewal TJ, Zaidi R, Brake J, Oram RA, Narendran P, Andrews RA, Cocks M, et al (2022). Free-living high intensity interval training and moderate intensity continuous training increases glycaemic variability and hypoglycaemia immediately after and the next day after exercise in people with type 1 diabetes.  Author URL.
Tecklenborg J, Thomas NJ, Jones AG, Oram RA (2021). A type 1 diabetes diagnostic model including type 1 diabetes genetic risk score and clinical features aids in classification of adult patients with clinical type 1 diabetes that are islet autoantibody negative.  Author URL.
Green HD, Thomas NJ, Tyrrell J, Jones A, Evans JP, Smith C, Oram RA, Jones AG, Weedon MN (2021). Genetic analysis confirms type 1 diabetes is a cause of multiple musculoskeletal conditions.  Author URL.
Carr A, Oram R, Narendran P, Andrews R (2021). MEASUREMENT OF C-PEPTIDE AT DIAGNOSIS INFORMS GLYCEMIC CONTROL BUT NOT HYPOGLYCEMIC RISK IN TYPE 1 DIABETES.  Author URL.
Gilchrist M, Casanova F, Tyrrell J, Fife N, Young K, Oram R, Weedon M (2021). MO042PREVALENCE OF FABRY DISEASE CAUSING VARIANTS IN THE UK BIOBANK. Abstract.
Shaw AC, Taylor GS, McDonald TJ, Oram RA, Shaw JAM, West DJ (2021). The influence of residual beta cell function upon free-living postprandial and nocturnal glycaemic control in individuals with type 1 diabetes.  Author URL.
Tippett PW, Hill AV, Bolt R, Lynam AL, Carr ALJ, Hattersley AT, McDonald TJ, Oram RA, Shields BM, Jones AG, et al (2020). A clinical prediction model combining clinical features and type 1 diabetes genetic risk has high accuracy for classification of adult onset diabetes at diagnosis.  Author URL.
Carr ALJ, Sharp SA, Young KG, Thomas NJ, Hattersley AT, Jones AG, Oram RA (2020). A type 1 diabetes genetic risk score is discriminative of adult-onset type 1 diabetes.  Author URL.
Carr ALJ, Inshaw JRJ, Flaxman CS, Leete P, Morgan NG, Todd JA, Oram RA, Richardson SJ, Besser REJ (2020). Circulating C-peptide levels mirror patterns of residual beta cell mass in the pancreas of children and young people with type 1 diabetes.  Author URL.
Sharp SA, Locke J, Killian M, Weedon MN, van Heel D, Turner JM, Oram RA, Hagopian WA (2020). Development and validation of a dried blood spot genotyping panel for prediction and diagnosis of type 1 diabetes and coeliac disease.  Author URL.
Ferrat LA, Dennis JM, Owen KR, Oram RA, Jones AG, Shields BM, Lynam AL (2020). Early development of insulinopenia in Black African men with dysglycaemia.  Author URL.
Ferrat LA, Vehik K, Sharp SA, Lernmark A, Ziegler A, Rewers M, She J-X, Toppari J, Akolkar B, Krischer J, et al (2019). A Combined Method Improves Risk Prediction for Childhood Type 1 Diabetes in the TEDDY Study.  Author URL.
Oram RA, Sharp SA, Pihoker C, Ferrat LA, Imperatore G, Saydah S, Williams AH, Wagenknecht LE, Lawrence JM, Weedon MN, et al (2019). A T1D Genetic Risk Score Combined with Clinical Features and Autoantibodies Enables Accurate Diabetes Classification in a Racial/Ethnically Diverse Population: the Search for Diabetes in Youth Study.  Author URL.
Sharp S, Jones S, Kimmitt R, Weedon M, Halpin A, Wood A, King S, Beaumont R, Hagopian W, Turner J, et al (2019). DEVELOPMENT AND CLINICAL VALIDATION OF a GENETIC RISK SCORE FOR COELIAC DISEASE.  Author URL.
Sharp SA, Jones SE, Kimmitt RA, Weedon MN, Halpin A, Wood AR, King S, Beaumont RN, Hagopian WA, Turner JM, et al (2019). Development of a genetic risk score for coeliac disease and validation in a clinical diagnostic setting.  Author URL.
Carr A, Perry D, Flaxman C, Shields B, Atkinson MA, Brusko TM, Richardson S, Oram RA (2019). Histological validation of the Type 1 diabetes genetic risk score as a biomarker for diabetes classification.  Author URL.
Grubb AL, Donnelly LA, Slieker RC, McDonald TJ, Rutters F, 't Hart LM, Pearson ER, Hattersley AT, Shields BM, Jones AG, et al (2018). A Type 1 diabetes genetic risk score can identify patients with glutamic acid decarboxylase (GAD) antibody-positive Type 2 diabetes with and without rapid progression to insulin therapy.  Author URL.
Sharp SA, Weedon MN, Hattersley AT, Hagopian W, Oram RA (2018). An improved genetic risk score to identify and discriminate Type 1 diabetes.  Author URL.
Grubb AL, Patel K, Oram RA, Hill AV, Angwin C, McDonald TJ, Weedon MN, Hattersley AT, Owen KR, Shields BM, et al (2018). Development and validation of a clinical prediction model to identify adult patients (aged 18-50) with type 1 diabetes requiring early insulin therapy.  Author URL.
Oldershaw HS, Oram RA, Shields BM, Andrews RC (2018). Diet and diet plus physical activity improves treatment satisfaction with no adverse effect on quality of life and illness perception in early Type 2 diabetes: Data from the Early ACTID trial.  Author URL.
Kimmitt RA, Dennis JM, Weedon M, Rodgers LR, Jones AG, Pearson ER, Hattersley AT, Oram RA, Shields BM (2018). Higher estimated glomerular filtration rate (eGFR) is associated with improved glycaemic response to sodium-glucose co-transporter-2 (SGLT2) inhibitors in patients with Type 2 diabetes and normal renal function: a MASTERMIND study.  Author URL.
Oldershaw HS, Oram RA, Dennis J, Andrews RC (2018). No deterioration in quality of life, treatment satisfaction and wellbeing over 6 years of follow up in people with recently diagnosed type 2 diabetes.  Author URL.
Oram RA, McDonald TJ, Sabbah S, Bloem S, Shields B, Hill A, Bolt R, Begom S, Khatri L, Tree T, et al (2018). Older age of diagnosis is the major feature of persistent long term endogenous insulin secretion in type 1 diabetes.  Author URL.
Marren SM, Hammersley S, Knight B, Bolt R, Hill A, Hattersley AT, McDonald TJ, Jones AG, Oram RA (2018). Preserved beta cell function in long-duration Type 1 diabetes is associated with markedly lower hypoglycaemia and insulin dose but no improvements in HbA1c, suggesting the need to intensify therapy.  Author URL.
Oram RA, Hammersley S, Knight BA, Bolt R, Hill A, Jones AG, Hattersley AT, McDonald TJ (2018). Proinsulin measurement suggests persistent beta cells even in those with undetectable c-peptide in long-duration Type 1 diabetes: Evidence for disordered insulin processing.  Author URL.
Hammersley SE, Bolt RL, Hill AV, McDonald TJ, Oram RA, Hattersley AT (2017). A novel patient focused approach enables study participation and aids recruitment rate in Type 1 diabetes research.  Author URL.
Oram RA, Leete P, Shields B, Richardson S, Hill A, McDonald T, Morgan N, Hattersley A (2017). C-peptide measurements support the existence of two distinct subtypes of Type 1 diabetes as defined by pancreatic immunopathology.  Author URL.
Grubb AL, Patel KA, Oram RA, Hill AV, Angwin C, McDonald TJ, Weedon MN, Hattersley AT, Shields BV, Jones AG, et al (2017). Development of a risk calculator to identify patients with Type 1 diabetes who will require early insulin therapy.  Author URL.
Patel KA, Hill A, Shields BM, Oram RA, Jones A, Hattersley AT (2017). Type 2 diabetes and severe insulin deficiency.  Author URL.
Patel KA, Oram RA, Mcdonald TJ, Hudson M, Colclough K, Ellard S, Weedon MN, Pearson EZ, Hattersley AT (2016). Classifying the unclassified using Type 1 diabetes genetic risk score: patients with young onset diabetes who are islet autoantibody negative and have preserved c-peptide.  Author URL.
Oram RA, Hammersley S, Hill A, Shields B, Hattersley A, McDonald T (2016). Longitudinal study of extremely low c-peptide: evidence for persistent beta cells in all people with Type 1 diabetes.  Author URL.
Oram RA, Hill A, Mcdonald TJ, Patel KA, Jones AG, Hattersley AT, Weedon MN (2015). A Novel, Inexpensive Test can Discriminate between Type 1 and Type 2 Diabetes.  Author URL.
Patel KA, Weedon MN, Ellard S, Oram RA, Hattersley AT (2015). Type 1 Diabetes Genetic Risk Score-A Novel Tool to Differentiate Monogenic Diabetes from T1D.  Author URL.
Patel KA, Weedon MN, Ellard S, Hattersley AT, Oram RA (2015). Type 1 diabetes genetic risk score: a novel tool to differentiate monogenic diabetes from Type 1 diabetes.  Author URL.
Oram RA, McDonald TJ, Shields BM, Pearson ER, Hattersley AT (2014). A large, population-based study demonstrates that most people with long duration Type 1 diabetes are insulin microsecretors and produce their own endogenous insulin.  Author URL.
Hope SV, Taylor PJ, Shields BM, Oram RA, Chakera A, Hattersley AT (2014). Are we missing hypoglycaemia in elderly people?. 10th Congress of the European Union Geriatric Medicine Society. 17th - 19th Sep 2014.
Hope SV, Taylor PJ, Shields BM, Oram RA, Chakera AJ, Strain WD, Hattersley AT (2014). Non-specific symptoms associated with hypoglycaemia in the elderly are common in patients treated with metformin only, as well as those treated with insulin or sulphonylureas.  Author URL.
So K, Bewshea CM, Heap GA, Muller AF, Delaney MP, Daneshmend TK, Hart AL, Orchard TR, Irving PM, D'Souza R, et al (2013). 5-Aminosalicylate (5-ASA) Induced Nephrotoxicity in Inflammatory Bowel Disease.  Author URL.
Hudson MM, Shepherd M, Oram RA, McDonald TJ, Ellard S, Shields BM, Hattersley AT (2013). A population-based approach to genetic testing defines the prevalence of maturity onset diabetes of the young (MODY) in patients with diabetes diagnosed under 30 years as 3%.  Author URL.
Oram RA, McDonald TJ, Jones AG, Besser REJ, Hattersley AT (2013). The majority of patients with over five years of Type 1 diabetes are insulin microsecretors and have functioning beta cells.  Author URL.
Sanders T, Oram RA, Shepherd M, Pearson ER, MacDonald TJ, Ellard S, Shields BM, Hattersley AT (2013). Time to reconsider? Reassessment of diagnosis in long duration Type 1 diabetes with urinary C-peptide creatinine ratio and antibodies identifies people with alternate diagnoses.  Author URL.
Oram RA, Shepherd MH, Hudson M, Sanders T, Tiley S, Hammersley S, Shields B, McDonald TJ, Knight BA, Besser REJ, et al (2012). The prevalence of endogenous insulin production in a cohort of adults with type 1 diabetes.  Author URL.
Jones AG, Besser REJ, McDonald TJ, Shields BM, Hope SV, Bowman PA, Oram RA, Knight BA, Hattersley AT (2011). Measuring endogenous insulin secretion: does it matter in insulin treated patients?. Diabetes UK Annual Professional Conference 2011. 30th Mar - 1st Apr 2011.
Jones AG, Besser REJ, Shields BM, McDonald TJ, Hope SV, Oram RA, Knight BA, Hattersley AT (2011). Practical alternatives to the mixed meal tolerance test in insulin treated diabetes. Diabetes UK Annual Professional Conference 2011. 30th Mar - 1st Apr 2011.
Sansbury FH, Bromilow G, Bingham C, Powell R, Nicholls A, Oram RA, Strain L, Goodship THJ, Warwicker P, Turnpenny PD, et al (2010). Atypical haemolytic uraemic syndrome in one large kindred predisposed by factor H mutation penetrance data based on mutation testing and family history.  Author URL.

Back to top

Supervision / Group

Research Fellows

  • Michelle Hudson EXE T1D and TIGI Senior Project manager
  • Becky Dobbs Research administrator/manager on EXE T1D study

Postdoctoral researchers

  • Lauric Ferrat Post-doctoral fellow studying combined prediction of type 1 diabetes using genetic risk scores and other biomarkers.
  • Jonathan Locke Lecturer studying methods for quick and easy generation of type 1 diabetes genetic risk score
  • Steven Squires

Postgraduate researchers

  • Alice Carr PhD student studying associations of persistent C-peptide in type 1 diabetes.
  • Seth Sharp PhD student studying polygenic risk scores in type 1 diabetes and other autoimmune diseases
  • Kittiya Sukcharoen Clinical Fellow studying polygenic risk in renal disease

Research Technicians

  • Luke Weymouth

Alumni

  • Jamie Harrison
  • Shannon Marren
  • Henry Oldershaw

Back to top

Edit Profile